Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 8.4 | 4.7 | 4.6 | 3.8 |
| Revenue growth | 81.4% | 0.4% | 23.5% | |
| Cost of goods sold | 3.1 | 1.5 | 1.8 | 1.8 |
| Gross profit | 5.3 | 3.1 | 2.8 | 1.9 |
| Gross margin | 62.9% | 67.3% | 61.5% | 51.9% |
| Sales and marketing | 0.2 | 0.1 | | |
| Research and development | | | 3.6 | 4.2 |
| General and administrative | | | 11.7 | 10.8 |
| EBITA | -94.1 | -31.8 | -23.0 | -22.3 |
| EBITA margin | -1115.2% | -683.6% | -495.5% | -594.0% |
| Amortization of intangibles | 2.9 | 3.2 | | |
| EBIT | -97.0 | -35.0 | -23.0 | -22.3 |
| EBIT margin | -1149.5% | -752.4% | -495.5% | -594.0% |
| Pre-tax income | -159.6 | -68.0 | 0.0 | 0.0 |
| Income taxes | 0.6 | 0.5 | 0.0 | 0.0 |
| Net income | -159.6 | -68.0 | 0.0 | 0.0 |
| Net margin | -1891.0% | -1462.3% | 0.0% | 0.0% |
| |
| Diluted EPS | ($2.03) | ($1.11) | | |
| Shares outstanding (diluted) | 78.5 | 61.5 | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|